Table: Kyowa Kirin -2021 group results (IFRS)
Feb 7 (Reuters)-
Kyowa Kirin Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2021 Dec 31, 2020 Dec 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULT FORECAST H1 FORECAST
Sales 352.25 318.35 380.00
(+10.6 pct) (+4.1 pct) (+7.9 pct)
Operating
Pretax 60.05 52.26 66.00
(+14.9 pct) (+17.5 pct) (+9.9 pct)
Net 52.35 47.03 53.00
(+11.3 pct) (-29.9 pct) (+1.2 pct)
EPS Basic 97.43 yen 87.56 yen 98.64 yen
EPS Diluted 97.39 yen 87.50 yen
Ann Div 46.00 yen 44.00 yen 48.00 yen
-Q2 Div 23.00 yen 22.00 yen 24.00 yen
-Q4 Div 23.00 yen 22.00 yen 24.00 yen
NOTE - Kyowa Kirin Co., Ltd..
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4151.T
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia